Dr. Louis Weinstein, M.D

NPI: 1124047071
Total Payments
$15,695
2022 Payments
$7,960
Companies
6
Transactions
41

Payment Breakdown by Category

Consulting$15,695 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $15,695 41 100.0%

Top Paying Companies

Company Total Records Latest Year
AMAG Pharmaceuticals, Inc. $11,400 36 $0 (2022)
HRA Pharma $3,150 1 $0 (2022)
Alnylam Pharmaceuticals Inc. $310.00 1 $0 (2019)
Vertex Pharmaceuticals Incorporated $310.00 1 $0 (2022)
Cepheid $300.00 1 $0 (2020)
Clinical Innovations, LLC $225.00 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2022 $7,960 3 AMAG Pharmaceuticals, Inc. ($4,500)
2020 $300.00 1 Cepheid ($300.00)
2019 $7,210 36 AMAG Pharmaceuticals, Inc. ($6,900)
2018 $225.00 1 Clinical Innovations, LLC ($225.00)

All Payment Transactions

41 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/06/2022 HRA Pharma Consulting Fee Cash or cash equivalent $3,150.00 General
11/22/2022 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $4,500.00 General
Category: Reduction of risk for preterm birth
11/07/2022 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $310.00 General
11/03/2020 Cepheid GENEXPERT (Device) Consulting Fee Cash or cash equivalent $300.00 General
Category: MOLECULAR DIAGNOSTICS
10/22/2019 Alnylam Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $310.00 General
10/18/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $94.47 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/18/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $74.77 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/18/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $24.05 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/18/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $17.17 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/17/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $69.41 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/17/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $64.94 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/17/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $46.65 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/17/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $44.59 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/16/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $3,125.00 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/16/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $410.30 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/16/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $114.02 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/16/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee Cash or cash equivalent $85.32 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/16/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $60.12 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/16/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $49.74 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
10/16/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $14.64 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
09/13/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $250.00 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
09/13/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $88.91 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
09/13/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $79.97 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
09/13/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $33.50 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH
09/13/2019 AMAG Pharmaceuticals, Inc. MAKENA (Drug) Consulting Fee In-kind items and services $20.00 General
Category: REDUCTION OF RISK FOR PRETERM BIRTH

About Dr. Louis Weinstein, M.D

Dr. Louis Weinstein, M.D is a Obstetrics & Gynecology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124047071.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Louis Weinstein, M.D has received a total of $15,695 in payments from pharmaceutical and medical device companies, with $7,960 received in 2022. These payments were reported across 41 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($15,695).

Practice Information

  • Specialty Obstetrics & Gynecology
  • Other Specialties Maternal & Fetal Medicine
  • Location Philadelphia, PA
  • Active Since 07/19/2006
  • Last Updated 07/20/2011
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1124047071

Products in Payments

  • MAKENA (Drug) $11,400
  • GENEXPERT (Device) $300.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Philadelphia